Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization

被引:86
作者
Jones, RL [1 ]
Salamonsen, LA [1 ]
Zhao, YC [1 ]
Ethier, JF [1 ]
Drummond, AE [1 ]
Findlay, JK [1 ]
机构
[1] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
关键词
activin receptors; betaglycan; decidualization; follistatin; implantation;
D O I
10.1093/molehr/8.4.363
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Decidualization of the human endometrium is critical for implantation, but the mechanisms involved are largely unknown. Activin subunits are expressed in endometrium during decidualization. From its known actions in cell differentiation and tissue remodelling, we hypothesized that activin A is involved in the paracrine regulation of decidualization. We examined the expression of activin receptors (ActRs) by semi-quantitative and real-time RT-PCR. mRNA for all ActR subtypes (Ia, Ib, IIa and IIb) was detected in endometrium, with maximal expression in the early secretory phase and in early pregnancy. ActR protein was localized exclusively to stromal and endothelial cells. This expression pattern was confirmed by in-situ hybridization. Activin bioavailability is locally regulated by its binding protein, follistatin, and also by the antagonist, inhibin. Inhibin competition for ActRII binding is enhanced by the binding protein, betaglycan. Follistatin and betaglycan were also detected in the endometrium, localized to stromal and epithelial cells. This co-expression of activin subunits, receptors and binding proteins indicates that stromal cells are capable of responding to activin, and that there is tight local regulation of activin action within the endometrium. As activin production is up-regulated in decidual cells, this provides further evidence for an involvement of activins during stromal cell decidualization.
引用
收藏
页码:363 / 374
页数:12
相关论文
共 72 条
[1]  
Barker D J, 1997, Rev Reprod, V2, P105, DOI 10.1530/ror.0.0020105
[2]  
BELL SC, 1991, ANN NY ACAD SCI, V622, P120
[3]   Activin is a local regulator of human cytotrophoblast cell differentiation [J].
Caniggia, I ;
Lye, SJ ;
Cross, JC .
ENDOCRINOLOGY, 1997, 138 (09) :3976-3986
[4]   Structure and expression of a membrane component of the inhibin receptor system [J].
Chong, HR ;
Pangas, SA ;
Bernard, DJ ;
Wang, E ;
Gitch, J ;
Chen, W ;
Draper, LB ;
Cox, ET ;
Woodruff, TK .
ENDOCRINOLOGY, 2000, 141 (07) :2600-2607
[5]   Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces Smad6 expression [J].
Clarke, TR ;
Hoshiya, Y ;
Yi, SE ;
Liu, XH ;
Lyons, KM ;
Donahoe, PK .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (06) :946-959
[6]   Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors [J].
deWinter, JP ;
tenDijke, P ;
deVries, CJM ;
vanAchterberg, TAE ;
Sugino, H ;
deWaele, P ;
Huylebroeck, D ;
Verschueren, K ;
vandenEijndenvanRaaij, AJM .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 116 (01) :105-114
[7]  
DIMITRIADIS E, 2001, SRB ANN SCI M AUSTR, V32, P8
[8]  
DRUMMOND AE, 2002, IN PRESS ENDOCRINOLO
[9]   Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin [J].
Evans, LW ;
Muttukrishna, S ;
Groome, NP .
JOURNAL OF ENDOCRINOLOGY, 1998, 156 (02) :275-282
[10]   The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4 [J].
Fainsod, A ;
Deissler, K ;
Yelin, R ;
Marom, K ;
Epstein, M ;
Pillemer, G ;
Steinbeisser, H ;
Blum, M .
MECHANISMS OF DEVELOPMENT, 1997, 63 (01) :39-50